
Cisatracurium Besylate
To report suspected adverse reactions 1-800-FDA-1088 PRINCIPAL DISPLAY PANEL. NDC 0143- 9396 -01 Rx only Cisatracurium Besylate Injection USP. 10 mg per 5 mL (2 mg/mL) WARNING: Paralyzing…
To report suspected adverse reactions 1-800-FDA-1088 PRINCIPAL DISPLAY PANEL. NDC 0143- 9396 -01 Rx only Cisatracurium Besylate Injection USP. 10 mg per 5 mL (2 mg/mL) WARNING: Paralyzing…
To report SUSPECTED ADVERSE REACTIONS, contact Hikma Pharmaceuticals USA Inc at 1-877-845-0689 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. PRINCIPAL DISPLAY PANEL. NDC 0143- 9151…
To report SUSPECTED ADVERSE REACTIONS, contact Hikma Pharmaceuticals USA Inc at 1-877-845-0689 or FDA at 1-800-332-1088 or www.fda.gov/medwatch. “1-800-FDA-1088” PRINCIPAL DISPLAY PANEL…
The following are discussed in more detail in other sections of the labeling. Hypersensitivity Reactions [see. Warnings and Precautions (5.1)] Dermatological Toxicity [see…
The following serious adverse reactions are discussed in greater detail in other sections: Cardiorespiratory Adverse Reactions [see. Warnings and Precautions (5.3.)] Paradoxical Behavior…
This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.
Privacy Policy | Copyright © 2023. All Rights Reserved.